ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235358.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.026304268	Resistant
ENSG00000235358.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.049091647	Sensitive